glp 1 neurotransmitter Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression | Pharmacological Reports Repurposing glucagon-like peptide-1 receptor agonists

LDN is mainly used off-label for chronic pain, autoimmune disorders, and inflammatory diseases

Exposure to phentermine or GLP-1 medications in the first trimester yielded similar results to exposure in the 90 days prior to pregnancy, as shown in Figure 3

The first human-based GLP-1RA to be evaluated in clinical trials for OW dosing was taspoglutide (BIM-51077, Aib8,35 GLP-1 [7-36] amide, Roche)

Semaglutide and tirzepatide are once-weekly injectable medications approved for chronic weight management, used in conjunction with lifestyle changes

A promising therapeutic option is currently being developed in the context of the European research project called Rose (Restoring Odorant Detection and Recognition in Smell Deficit): the development of an artificial nose, an olfactory prosthesis that can restore odour perception in anosmic patients